Besiktas, Turkey

Gulsah Aydin

This inventor holds 3 USPTO granted patents and 3 published patent applications. Top assignees: Bahçesehir Üniversitesi, Istanbul Teknik Üniversitesi. Active years: 2025-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Gulsah Aydin. Retrieved from https://idiyas.com/inventor/gulsah-aydin

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 3 

% Patents Active = 33.3

Average Co-Inventor Count = 6.0

ph-index = 1


Company Filing History:


Years Active: 2025-2026

Loading Chart...
3 patents (USPTO):Explore Patents

Title: Gulsah Aydin: Innovator in MDM2 Inhibition

Introduction

Gulsah Aydin is a prominent inventor based in Besiktas, Turkey. She has made significant contributions to the field of pharmaceutical innovation, particularly in the development of novel inhibitors for cancer treatment.

Latest Patents

Aydin holds a patent for the compound DRG-MDM2-6, which serves as a novel mouse double minute 2 (MDM2) inhibitor. This invention relates to a compound represented by formula (I) or a pharmaceutically acceptable derivative thereof, aimed at inhibiting MDM2 activity.

Career Highlights

Throughout her career, Aydin has worked with esteemed institutions such as Istanbul Technical University and Bahçesehir University. Her work has focused on advancing research in the pharmaceutical sciences, contributing to the development of innovative therapeutic solutions.

Collaborations

Aydin has collaborated with notable colleagues, including Maide Nur Paksoy and Timucin Avsar, enhancing her research through teamwork and shared expertise.

Conclusion

Gulsah Aydin's contributions to the field of MDM2 inhibition exemplify her dedication to innovation in pharmaceutical research. Her work continues to pave the way for advancements in cancer treatment.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…